These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 27871302

  • 1. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
    Qurashi I, Chu S, Husain N, Drake RJ, Chaudhry I, Deakin JF.
    Trials; 2016 Nov 21; 17(1):553. PubMed ID: 27871302
    [Abstract] [Full Text] [Related]

  • 2. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study.
    Qurashi I, Chu S, Drake R, Hartley V, Chaudhry I, Deakin JFW, Husain N.
    Pilot Feasibility Stud; 2019 Nov 21; 5():79. PubMed ID: 31236286
    [Abstract] [Full Text] [Related]

  • 3. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
    Parr JR, Weldon E, Pennington L, Steen N, Williams J, Fairhurst C, O'Hare A, Lodh R, Colver A.
    Trials; 2014 Feb 17; 15():60. PubMed ID: 24533890
    [Abstract] [Full Text] [Related]

  • 4. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
    Segev A, Evans A, Hodsoll J, Whiskey E, Sheriff RS, Shergill S, MacCabe JH.
    Int Clin Psychopharmacol; 2019 Mar 17; 34(2):101-107. PubMed ID: 30614850
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
    Liang CS, Ho PS, Shen LJ, Lee WK, Yang FW, Chiang KT.
    Schizophr Res; 2010 Jun 17; 119(1-3):138-44. PubMed ID: 20299191
    [Abstract] [Full Text] [Related]

  • 6. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O, Lambert T.
    Psychopharmacology (Berl); 2020 Oct 17; 237(10):2905-2915. PubMed ID: 32876732
    [Abstract] [Full Text] [Related]

  • 7. Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.
    Kreinin A, Miodownik C, Mirkin V, Gaiduk Y, Yankovsky Y, Bersudsky Y, Lerner PP, Bergman J, Lerner V.
    J Clin Psychopharmacol; 2016 Jun 17; 36(3):200-5. PubMed ID: 27028980
    [Abstract] [Full Text] [Related]

  • 8. Trihexyphenidyl treatment of clozapine-induced hypersalivation.
    Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A.
    Int Clin Psychopharmacol; 1997 Jul 17; 12(4):213-5. PubMed ID: 9347382
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
    Man WH, Colen-de Koning JC, Schulte PF, Cahn W, van Haelst IM, Doodeman HJ, Egberts TC, Heerdink ER, Wilting I.
    J Clin Psychopharmacol; 2017 Apr 17; 37(2):155-161. PubMed ID: 28129312
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
    Takeuchi I, Hanya M, Uno J, Fujita K, Kamei H.
    Asia Pac Psychiatry; 2017 Dec 17; 9(4):. PubMed ID: 29193710
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study.
    Bai YM, Lin CC, Chen JY, Liu WC.
    J Clin Psychopharmacol; 2001 Dec 17; 21(6):608-11. PubMed ID: 11763010
    [Abstract] [Full Text] [Related]

  • 12. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR, Todhunter E, Pennington L, Stocken D, Cadwgan J, O'Hare AE, Tuffrey C, Williams J, Cole M, Colver AF.
    Arch Dis Child; 2018 Apr 17; 103(4):371-376. PubMed ID: 29192000
    [Abstract] [Full Text] [Related]

  • 13. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
    Kreinin A, Novitski D, Weizman A.
    Int Clin Psychopharmacol; 2006 Mar 17; 21(2):99-103. PubMed ID: 16421461
    [Abstract] [Full Text] [Related]

  • 14. Low-dose glycopyrrolate for clozapine-associated sialorrhea.
    Praharaj SK, Munoli RN, Sharma PS.
    J Clin Psychopharmacol; 2014 Jun 17; 34(3):392. PubMed ID: 24717248
    [No Abstract] [Full Text] [Related]

  • 15. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
    Blissit KT, Tillery E, Latham C, Pacheco-Perez J.
    Am J Health Syst Pharm; 2014 Aug 01; 71(15):1282-7. PubMed ID: 25027535
    [Abstract] [Full Text] [Related]

  • 16. Treatment effects of traditional Chinese medicines Suoquan Pill and Wuling Powder on clozapine-induced hypersalivation in patients with schizophrenia: study protocol of a randomized, placebo-controlled trial.
    Hung CC, Fu PK, Wang HY, Chan CH, Lan TH.
    Zhong Xi Yi Jie He Xue Bao; 2011 May 01; 9(5):495-502. PubMed ID: 21565135
    [Abstract] [Full Text] [Related]

  • 17. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
    Calderon J, Rubin E, Sobota WL.
    Int Clin Psychopharmacol; 2000 Jan 01; 15(1):49-52. PubMed ID: 10836287
    [Abstract] [Full Text] [Related]

  • 18. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
    Robb AS, Lee RH, Cooper EB, Siedel JV, Nusrat N.
    J Child Adolesc Psychopharmacol; 2008 Feb 01; 18(1):99-107. PubMed ID: 18294092
    [Abstract] [Full Text] [Related]

  • 19. Glycopyrrolate for clozapine-induced sialorrhea.
    Duggal HS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1546-7. PubMed ID: 17614181
    [No Abstract] [Full Text] [Related]

  • 20. Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia.
    Essali A, Rihawi A, Altujjar M, Alhafez B, Tarboush A, Alhaj Hasan N.
    Cochrane Database Syst Rev; 2013 Dec 19; 2013(12):CD009546. PubMed ID: 24353163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.